Cited by 248Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorForensic Toxicology and Drug Analysis

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram

Liechti, M·2000·Neuropsychopharmacology

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a recreational drug that has been shown to release serotonin (5-HT) and dopamine (DA) in animals. The effect of MDMA on 5-HT release can be blocked by 5-HT uptake inhibitors such as citalopram, suggesting that MDMA interacts with the 5-HT uptake site. It is unknown whether this mechanism is also responsible for the psychological effects of MDMA in humans. We investigated the effect of citalopram pretreatment (40 mg iv) on the psychological effects of MDMA (1.5 mg/kg po) in a double-blind placebo-controlled psychometric study in 16 healthy human volunteers. MDMA produced an emotional state with heightened mood, increased self-confidence and extroversion, moderate derealization, and an intensification of sensory perception. Most of these effects were markedly reduced by citalopram. This finding suggests that the psychological effects of MDMA are mediated via action at the 5-HT uptake site to increase 5-HT release through the carrier, as expected from animal studies.

Integrity signals

Registry

Crossref · 10.1016/s0893-133x(99)00148-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 47 · Cited by 248

Authors
Liechti, M.
Affiliations
Psychiatrische Universitätsklinik Zürich (CH)
Corresponding author
Liechti, M
Venue
Neuropsychopharmacology
Published
2000-05
Volume
22
Issue
5
Pages
513-521
ISSN
0893-133X (ISSN-L)
OpenAlex
W2120113858
Cited by
248
References
47
Citations by year
2026: 5 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 12 · 2021: 9 · 2020: 6 · 2019: 7 · 2018: 9 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 11 · 2013: 8 · 2012: 15
FWCI
16.96
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Heffter Research Institute
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
MDMA, ecstasy, citalopram, serotonin uptake inhibition, serotonin release, mood improvement, self-confidence, extraversion, derealization, sensory perception, drug interactions
MeSH terms
Adult, Brain, Double-Blind Method, Female, Hallucinogens, Humans, Male, Neuropsychological Tests, Citalopram, Selective Serotonin Reuptake Inhibitors, Nootropic Agents, N-Methyl-3,4-methylenedioxyamphetamine, Amphetamine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review